310 related articles for article (PubMed ID: 31060889)
21. Discovery of new biomarkers of idiopathic inflammatory myopathy.
Lu X; Peng Q; Wang G
Clin Chim Acta; 2015 Apr; 444():117-25. PubMed ID: 25681646
[TBL] [Abstract][Full Text] [Related]
22. Anti-nuclear matrix protein 2 antibody-positive inflammatory myopathies represent extensive myositis without dermatomyositis-specific rash.
Ichimura Y; Konishi R; Shobo M; Inoue S; Okune M; Maeda A; Tanaka R; Kubota N; Matsumoto I; Ishii A; Tamaoka A; Shimbo A; Mori M; Morio T; Kishi T; Miyamae T; Tanboon J; Inoue M; Nishino I; Fujimoto M; Nomura T; Okiyama N
Rheumatology (Oxford); 2022 Mar; 61(3):1222-1227. PubMed ID: 34152410
[TBL] [Abstract][Full Text] [Related]
23. Anti-TIF1γ antibody and the expression of TIF1γ in idiopathic inflammatory myopathies.
Kim Y; Song KS; Sohn EH; Kang SW; Yoo IS; Shim SC; Yoo SJ; Kim J
Int J Rheum Dis; 2019 Feb; 22(2):314-320. PubMed ID: 30398003
[TBL] [Abstract][Full Text] [Related]
24. Mitochondrial pathology in immune and inflammatory myopathies.
Varadhachary AS; Weihl CC; Pestronk A
Curr Opin Rheumatol; 2010 Nov; 22(6):651-7. PubMed ID: 20827203
[TBL] [Abstract][Full Text] [Related]
25. Identification of multiple cancer-associated myositis-specific autoantibodies in idiopathic inflammatory myopathies: a large longitudinal cohort study.
Yang H; Peng Q; Yin L; Li S; Shi J; Zhang Y; Lu X; Shu X; Zhang S; Wang G
Arthritis Res Ther; 2017 Nov; 19(1):259. PubMed ID: 29178913
[TBL] [Abstract][Full Text] [Related]
26. Idiopathic Inflammatory Myopathies: A Review of the Classification and Impact of Pathogenesis.
Mandel DE; Malemud CJ; Askari AD
Int J Mol Sci; 2017 May; 18(5):. PubMed ID: 28524083
[TBL] [Abstract][Full Text] [Related]
27. Acquired immune and inflammatory myopathies: pathologic classification.
Pestronk A
Curr Opin Rheumatol; 2011 Nov; 23(6):595-604. PubMed ID: 21934500
[TBL] [Abstract][Full Text] [Related]
28. Correlation of PMN elastase and PMN elastase-to-neutrophil ratio with disease activity in patients with myositis.
Wu S; Peng W; Zhang Y; Guo J; Fu J; Wang W
J Transl Med; 2019 Dec; 17(1):420. PubMed ID: 31842908
[TBL] [Abstract][Full Text] [Related]
29. Anti-Jo-1 antibody-positive patients show a characteristic necrotizing perifascicular myositis.
Mescam-Mancini L; Allenbach Y; Hervier B; Devilliers H; Mariampillay K; Dubourg O; Maisonobe T; Gherardi R; Mezin P; Preusse C; Stenzel W; Benveniste O
Brain; 2015 Sep; 138(Pt 9):2485-92. PubMed ID: 26198592
[TBL] [Abstract][Full Text] [Related]
30. [Clinical and pathological characteristics of immune mediated necrotizing myopathy].
Yang HX; Tian XL; Jiang W; Li WL; Liu QY; Peng QL; Wang GC; Lu X
Beijing Da Xue Xue Bao Yi Xue Ban; 2019 Dec; 51(6):989-995. PubMed ID: 31848492
[TBL] [Abstract][Full Text] [Related]
31. Inflammatory myopathy associated with anti-mitochondrial antibodies: A distinct phenotype with cardiac involvement.
Albayda J; Khan A; Casciola-Rosen L; Corse AM; Paik JJ; Christopher-Stine L
Semin Arthritis Rheum; 2018 Feb; 47(4):552-556. PubMed ID: 28893408
[TBL] [Abstract][Full Text] [Related]
32. Anti-Ku antibody-positive myositis presenting as a wide range of axial myopathies and myocarditis: A case report and review of the literature.
Kono M; Komai T; Yuki H; Hanata N; Kakumoto T; Kubota A; Hashimoto Maeda M; Toda T; Shoda H; Fujio K
Mod Rheumatol Case Rep; 2022 Jan; 6(1):64-68. PubMed ID: 34516654
[TBL] [Abstract][Full Text] [Related]
33. Murine models of idiopathic inflammatory myopathies.
Okiyama N; Konishi R; Ichimura Y
J Dermatol; 2024 Feb; ():. PubMed ID: 38321631
[TBL] [Abstract][Full Text] [Related]
34. The association between myositis-specific autoantibodies and muscle pathologies in idiopathic inflammatory myopathies.
Xu Q; Li QX; Bi FF; Duan HQ; Luo YB; Yang H
Clin Rheumatol; 2021 Feb; 40(2):613-624. PubMed ID: 32671659
[TBL] [Abstract][Full Text] [Related]
35. Classification of myositis.
Lundberg IE; de Visser M; Werth VP
Nat Rev Rheumatol; 2018 May; 14(5):269-278. PubMed ID: 29651121
[TBL] [Abstract][Full Text] [Related]
36. Idiopathic inflammatory myopathies.
van der Kooi AJ; de Visser M
Handb Clin Neurol; 2014; 119():495-512. PubMed ID: 24365315
[TBL] [Abstract][Full Text] [Related]
37. [Inflammatory myopathies: diagnosis and classifications].
Dimitri D
Presse Med; 2009; 38(7-8):1141-63. PubMed ID: 19282137
[TBL] [Abstract][Full Text] [Related]
38. Four dermatomyositis-specific autoantibodies-anti-TIF1γ, anti-NXP2, anti-SAE and anti-MDA5-in adult and juvenile patients with idiopathic inflammatory myopathies in a Hungarian cohort.
Bodoki L; Nagy-Vincze M; Griger Z; Betteridge Z; Szöllősi L; Dankó K
Autoimmun Rev; 2014 Dec; 13(12):1211-9. PubMed ID: 25182203
[TBL] [Abstract][Full Text] [Related]
39. Diagnostic value of additional histopathological fascia examination in idiopathic inflammatory myopathies.
Lim J; Eftimov F; Raaphorst J; Aronica E; van der Kooi AJ
Eur J Neurol; 2019 Dec; 26(12):1494-1496. PubMed ID: 31220379
[TBL] [Abstract][Full Text] [Related]
40. Review: immune-mediated necrotizing myopathies--a heterogeneous group of diseases with specific myopathological features.
Stenzel W; Goebel HH; Aronica E
Neuropathol Appl Neurobiol; 2012 Dec; 38(7):632-46. PubMed ID: 22989019
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
